ClinVar Miner

Submissions for variant NM_000335.5(SCN5A):c.3575G>A (p.Arg1192Gln)

gnomAD frequency: 0.00222  dbSNP: rs41261344
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 24
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Biesecker Lab/Clinical Genomics Section, National Institutes of Health RCV000171819 SCV000050843 benign Brugada syndrome 2013-06-24 criteria provided, single submitter research
GeneDx RCV000058578 SCV000171568 benign not provided 2020-04-29 criteria provided, single submitter clinical testing This variant is associated with the following publications: (PMID: 23465283, 22378279, 22995991, 24784157, 20129283, 15851227, 15992732, 18976777, 23853484, 15121794, 15689442, 22682427, 25051102, 20981092, 22519808, 17605181, 11823453, 26131924, 26159999, 27153395, 15851440, 16568155, 28472724, 28493952, 29672598, 29997009, 28498465, 30419068, 30079003, 31019283, 30677491, 31043699, 31539150, 31751991, 31918855, 28878402, 18245395, 33131149)
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000154828 SCV000204510 benign not specified 2013-10-18 criteria provided, single submitter clinical testing Arg1193Gln in exon 20 of SCN5A: This variant is not expected to have clinical si gnificance because it has been identified in 5.1% (20/394) Chinese chromosomes b y the 1000 Genomes Project (dbSNP rs41261344).
Labcorp Genetics (formerly Invitae), Labcorp RCV000058578 SCV000262483 benign not provided 2024-02-01 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV000154828 SCV000306543 benign not specified criteria provided, single submitter clinical testing
Ambry Genetics RCV000252422 SCV000318184 benign Cardiovascular phenotype 2016-02-01 criteria provided, single submitter clinical testing This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Illumina Laboratory Services, Illumina RCV000009990 SCV000443977 benign Brugada syndrome 1 2018-03-06 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute RCV000154828 SCV000748020 likely benign not specified 2016-12-28 criteria provided, single submitter clinical testing
Equipe Genetique des Anomalies du Developpement, Université de Bourgogne RCV000755697 SCV000883129 benign Long QT syndrome 3 2018-11-21 criteria provided, single submitter clinical testing
Color Diagnostics, LLC DBA Color Health RCV001841238 SCV000910629 benign Cardiac arrhythmia 2018-03-15 criteria provided, single submitter clinical testing
Athena Diagnostics RCV000058578 SCV001145504 likely benign not provided 2018-12-03 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000755697 SCV001308460 benign Long QT syndrome 3 2018-03-06 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
Illumina Laboratory Services, Illumina RCV001147624 SCV001308461 likely benign Progressive familial heart block, type 1A 2018-03-06 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease.
Illumina Laboratory Services, Illumina RCV001147625 SCV001308462 benign Sick sinus syndrome 1 2018-03-06 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
Illumina Laboratory Services, Illumina RCV001147626 SCV001308463 benign Ventricular fibrillation, paroxysmal familial, type 1 2018-03-06 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
Illumina Laboratory Services, Illumina RCV001147627 SCV001308464 likely benign Dilated cardiomyopathy 1E 2018-03-06 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease.
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000058578 SCV001472663 benign not provided 2022-03-30 criteria provided, single submitter clinical testing
Fulgent Genetics, Fulgent Genetics RCV002476954 SCV002797841 benign Brugada syndrome 1; Long QT syndrome 3; Sick sinus syndrome 1; Progressive familial heart block, type 1A; Ventricular fibrillation, paroxysmal familial, type 1; Dilated cardiomyopathy 1E; SUDDEN INFANT DEATH SYNDROME; Atrial fibrillation, familial, 10 2021-10-21 criteria provided, single submitter clinical testing
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario RCV003149566 SCV003838880 benign Cardiomyopathy 2021-09-15 criteria provided, single submitter clinical testing
Breakthrough Genomics, Breakthrough Genomics RCV000058578 SCV005258477 likely benign not provided criteria provided, single submitter not provided
OMIM RCV000009990 SCV000030211 pathogenic Brugada syndrome 1 2006-10-01 no assertion criteria provided literature only
OMIM RCV000009991 SCV000030212 risk factor Long QT syndrome 3, acquired, susceptibility to 2006-10-01 no assertion criteria provided literature only
Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust RCV000058578 SCV000090098 not provided not provided no assertion provided literature only This variant has been reported in the following publications (PMID:11823453;PMID:12639704;PMID:15121794;PMID:15689442;PMID:15851227;PMID:16155735;PMID:16707561;PMID:17210839;PMID:17905336;PMID:18245395;PMID:18976777;PMID:19841300;PMID:17605181;PMID:20981092;PMID:20129283).
Blueprint Genetics RCV000157488 SCV000207233 uncertain significance Primary familial hypertrophic cardiomyopathy 2014-04-17 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.